On Monday, Leap Therapeutics Inc (NASDAQ: LPTX) was 15.28% up from the session before settling in for the closing price of $3.60. A 52-week range for LPTX has been $1.31 – $5.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -20.00% over the last five years. When this article was written, the company’s average yearly earnings per share was at 54.87%. With a float of $29.73 million, this company’s outstanding shares have now reached $38.26 million.
The firm has a total of 54 workers. Let’s measure their productivity. In terms of profitability, gross margin is 64.98%, operating margin of -10367.51%, and the pretax margin is -9480.91%.
Leap Therapeutics Inc (LPTX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Leap Therapeutics Inc stocks. The insider ownership of Leap Therapeutics Inc is 22.30%, while institutional ownership is 32.18%.
Leap Therapeutics Inc (LPTX) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.51 earnings per share (EPS) during the time that was better than consensus figure (set at -0.58) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.49% during the next five years compared to 28.36% growth over the previous five years of trading.
Leap Therapeutics Inc (NASDAQ: LPTX) Trading Performance Indicators
You can see what Leap Therapeutics Inc (LPTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.00, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -1.22 in one year’s time.
Technical Analysis of Leap Therapeutics Inc (LPTX)
Analysing the last 5-days average volume posted by the [Leap Therapeutics Inc, LPTX], we can find that recorded value of 0.68 million was better than the volume posted last year of 0.23 million. As of the previous 9 days, the stock’s Stochastic %D was 84.74%. Additionally, its Average True Range was 0.32.
During the past 100 days, Leap Therapeutics Inc’s (LPTX) raw stochastic average was set at 96.11%, which indicates a significant increase from 95.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 89.12% in the past 14 days, which was higher than the 80.65% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.75, while its 200-day Moving Average is $2.64. Now, the first resistance to watch is $4.40. This is followed by the second major resistance level at $4.64. The third major resistance level sits at $5.04. If the price goes on to break the first support level at $3.76, it is likely to go to the next support level at $3.36. Should the price break the second support level, the third support level stands at $3.12.
Leap Therapeutics Inc (NASDAQ: LPTX) Key Stats
There are 25,600K outstanding shares of the company, which has a market capitalization of 158.78 million. As of now, sales total 0 K while income totals -81,410 K. Its latest quarter income was 0 K while its last quarter net income were -20,130 K.
